Compositions for the treatment of neurodegenerative diseases are disclosed. Methods of treating and monitoring progression of a neurodegenerative disease are disclosed. According to the present invention, a selective CB2 receptor modulator may be administered to a mammal for the treatment of a neurodegenerative disease.

 
Web www.patentalert.com

< Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors

> Novel dipodazine compounds and applications

> INHIBITORS OF ANTI-APOPTOTIC PROTEINS
~ 00519